(Q35686224)

9 August 2017

1 reference

title

Hypertensive renal damage: insights from animal models and clinical relevance (English)

1 reference

9 August 2017

Karen A Griffin

1

1 reference

9 August 2017

Anil K Bidani

series ordinal

2

1 reference

9 August 2017

language of work or name

1 reference

1 April 2004

1 reference

Current Hypertension Reports

9 August 2017

published in

1 reference

9 August 2017

volume

6

1 reference

9 August 2017

issue

2

1 reference

9 August 2017

page(s)

145-153

1 reference

Hemodynamic theory of progressive renal disease: a 10-year update in brief review

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0091-8

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0091-8

Evaluation and applications of radiotelemetry in small laboratory animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0091-8

Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0091-8

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11906-004-0091-8

Renal autoregulation: perspectives from whole kidney and single nephron studies

21 January 2018

1 reference

12 December 2020

Functional and structural correlates of glomerulosclerosis after renal mass reduction in the rat

1 reference

12 December 2020

Genetically determined chloride-sensitive hypertension and stroke

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis

1 reference

12 December 2020

Diurnal blood pressure variation and dietary salt in spontaneously hypertensive rats

1 reference

12 December 2020

Development and characteristics of inbred strains of Dahl salt-sensitive and salt-resistant rats.

1 reference

12 December 2020

Renal and nephron hemodynamics in spontaneously hypertensive rats

1 reference

12 December 2020

The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

1 reference

12 December 2020

Impaired autoregulation of the glomerular filtration rate in patients with nondiabetic nephropathies

1 reference

12 December 2020

Reduced reactivity of renal microvessels to pressure and angiotensin II in fawn-hooded rats.

1 reference

12 December 2020

Renal disease susceptibility and hypertension are under independent genetic control in the fawn-hooded rat

1 reference

12 December 2020

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

12 December 2020

Renal autoregulation and vulnerability to hypertensive injury in remnant kidney

1 reference

12 December 2020

Class differences in the effects of calcium channel blockers in the rat remnant kidney model

1 reference

12 December 2020

Autoregulation of glomerular filtration rate in patients with type 2 diabetes during isradipine therapy

1 reference

12 December 2020

Genetic susceptibility to hypertension-induced renal damage in the rat. Evidence based on kidney-specific genome transfer

1 reference

12 December 2020

The unique vulnerability of diabetic subjects to hypertensive injury

1 reference

12 December 2020

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

12 December 2020

Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications

1 reference

12 December 2020

Resetting of renal blood flow autoregulation in spontaneously hypertensive rats

1 reference

12 December 2020

Absence of glomerular injury or nephron loss in a normotensive rat remnant kidney model

1 reference

12 December 2020

Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

Drug treatment of hypertension

1 reference

12 December 2020

Dynamic autoregulation and renal injury in Dahl rats

1 reference

12 December 2020

Genetics of experimental hypertension.

1 reference

12 December 2020

Long-term renal consequences of hypertension for normal and diseased kidneys

1 reference

12 December 2020

Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model

1 reference

12 December 2020

"Step" vs. "dynamic" autoregulation: implications for susceptibility to hypertensive injury.

1 reference

12 December 2020

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

12 December 2020

Glomerular hypertension, abnormal glomerular growth, and progression of renal diseases

1 reference

12 December 2020

Renal myogenic response: kinetic attributes and physiological role.

1 reference

12 December 2020

Aldosterone in renal disease

1 reference

12 December 2020

Method of renal mass reduction is a critical modulator of subsequent hypertension and glomerular injury

1 reference

12 December 2020

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

12 December 2020

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis

1 reference

12 December 2020

Impaired autoregulation of glomerular capillary hydrostatic pressure in the rat remnant nephron

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Differential salt-sensitivity in the pathogenesis of renal damage in SHR and stroke prone SHR

1 reference

12 December 2020

Renoprotective effects of felodipine and/or enalapril in spontaneously hypertensive rats with and without L-NAME

1 reference

12 December 2020

Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?

1 reference

12 December 2020

Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes

1 reference

12 December 2020

Hypertension trials: 1990 to 2000.

1 reference

12 December 2020

Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo

1 reference

12 December 2020

Plasma and skeletal muscle electrolytes in patients on long-term diuretic therapy for arterial hypertension and/or congestive heart failure

1 reference

12 December 2020

Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent

1 reference

12 December 2020

Radiotelemetric BP monitoring, antihypertensives and glomeruloprotection in remnant kidney model

1 reference

12 December 2020

A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat Via Radio-telemetry

1 reference

12 December 2020

Genetics of renal damage in primary hypertension

1 reference

12 December 2020

Progression of diabetic nephropathy

1 reference

12 December 2020

Low protein diet mediated renoprotection in remnant kidneys: Renal autoregulatory versus hypertrophic mechanisms

1 reference

12 December 2020

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

12 December 2020

Patterns of blood pressure variability in normotensive and hypertensive rats

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

12 December 2020

Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function.

1 reference

12 December 2020

Lack of evidence of blood pressure-independent protection by renin-angiotensin system blockade after renal ablation

1 reference

12 December 2020

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

12 December 2020

Renal dysfunction complicating the treatment of hypertension

1 reference

12 December 2020

False claims of blood pressure-independent protection by blockade of the renin angiotensin aldosterone system?

1 reference

12 December 2020

Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy

1 reference

12 December 2020

Deleterious effects of calcium channel blockade on pressure transmission and glomerular injury in rat remnant kidneys

1 reference

12 December 2020

Increased genetic susceptibility to renal damage in the stroke-prone spontaneously hypertensive rat

1 reference

12 December 2020

Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients

1 reference

12 December 2020

Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy

1 reference

12 December 2020

Stroke prevention by losartan in stroke-prone spontaneously hypertensive rats

1 reference

12 December 2020

The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE>

1 reference

12 December 2020

Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials

1 reference

12 December 2020

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

12 December 2020

Stroke-prone spontaneously hypertensive rats as an experimental model of malignant hypertension. A pathological study.

1 reference

12 December 2020

Angiotensin-converting enzyme inhibition: facts and fiction

1 reference

12 December 2020

Blood pressure lability and glomerulosclerosis after normotensive 5/6 renal mass reduction in the rat.

1 reference

12 December 2020

Altered myogenic responsiveness of the renal microvasculature in experimental hypertension.

1 reference

12 December 2020

Cerebral blood flow and its pathophysiology in hypertension

1 reference

12 December 2020

Comparative effects of ramipril on ambulatory and office blood pressures: a HOPE Substudy.

1 reference

12 December 2020

Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

10.1007/S11906-004-0091-8

Identifiers

DOI

1 reference

9 August 2017

1 reference